Some groups have found that bortezomib increases the stress kinase JNK pathway to induce apoptosis in myeloma cells (17) or cell death by overproduction of mitochondrial ROS (18); others suggest that the JNK signaling in myeloma cells induces their proliferation and PI-resistance (19, 20). This evidence concerns the gene MAPK8 and plasma cell myeloma.